Lv5
1040 积分 2025-08-21 加入
Prevalence of obesity and associated complications in China: A cross‐sectional, real‐world study in 15.8 million adults
23小时前
已完结
The Venice Declaration: Obesity as a Disease—A Call to Action for Diagnosis, Multimodal Treatment, and Policy Change
1天前
已完结
The Asian Pacific association for the study of the liver clinical practice guidelines for the diagnosis and management of metabolic dysfunction-associated fatty liver disease
1天前
已完结
Type 2 diabetes: summary of updated NICE guidance
25天前
已完结
Particulate matter of air pollution may increase risk of kidney failure in IgA nephropathy
30天前
已完结
Aldosterone and Treatment-Resistant Hypertension
1个月前
已完结
Aficamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy
1个月前
已完结
Asian Expert Consensus on Nocturnal Hypertension Management
1个月前
已完结
Safety and tolerability of semaglutide across the SUSTAIN and PIONEER phase IIIa clinical trial programmes
1个月前
已完结
Efficacy and safety of once-daily oral orforglipron compared with oral semaglutide in adults with type 2 diabetes (ACHIEVE-3): a multinational, multicentre, non-inferiority, open-label, randomised, phase 3 trial
1个月前
已完结
皖公网安备34019202002308
